IN191030B - - Google Patents

Info

Publication number
IN191030B
IN191030B IN84MU2001A IN191030B IN 191030 B IN191030 B IN 191030B IN 84MU2001 A IN84MU2001 A IN 84MU2001A IN 191030 B IN191030 B IN 191030B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Bipin Pandey
Vidya Bhushan Lohray
Braj Bhushan Lohray
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to IN84MU2001 priority Critical patent/IN191030B/en
Priority to US10/054,101 priority patent/US6635763B2/en
Priority to MXPA03006133A priority patent/MXPA03006133A/es
Priority to AU2002228325A priority patent/AU2002228325B2/en
Priority to PT02710298T priority patent/PT1353928E/pt
Priority to PL02365281A priority patent/PL365281A1/xx
Priority to KR1020067008009A priority patent/KR20060040758A/ko
Priority to KR1020037009826A priority patent/KR100632748B1/ko
Priority to EP02710298A priority patent/EP1353928B1/en
Priority to ES02710298T priority patent/ES2278010T3/es
Priority to PCT/IN2002/000012 priority patent/WO2002059128A2/en
Priority to JP2002559430A priority patent/JP5000841B2/ja
Priority to BR0207064-2A priority patent/BR0207064A/pt
Priority to EA200300831A priority patent/EA006198B2/ru
Priority to CNB02803998XA priority patent/CN100338068C/zh
Priority to DE60217062T priority patent/DE60217062T2/de
Priority to DK02710298T priority patent/DK1353928T3/da
Priority to CA2436323A priority patent/CA2436323C/en
Priority to AT02710298T priority patent/ATE349451T1/de
Priority to NO20032898A priority patent/NO327807B1/no
Priority to ZA200304895A priority patent/ZA200304895B/en
Publication of IN191030B publication Critical patent/IN191030B/en
Priority to CY20071100280T priority patent/CY1106346T1/el
Priority to JP2008179540A priority patent/JP2009029805A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN84MU2001 2001-01-24 2001-01-24 IN191030B (ar)

Priority Applications (23)

Application Number Priority Date Filing Date Title
IN84MU2001 IN191030B (ar) 2001-01-24 2001-01-24
US10/054,101 US6635763B2 (en) 2001-01-24 2001-10-22 Process to prepare clopidogrel
JP2002559430A JP5000841B2 (ja) 2001-01-24 2002-01-21 クロピドグレルの製造方法
EA200300831A EA006198B2 (ru) 2001-01-24 2002-01-21 Способ получения клопидогрела
PT02710298T PT1353928E (pt) 2001-01-24 2002-01-21 Processo para preparar clopidogrel
PL02365281A PL365281A1 (en) 2001-01-24 2002-01-21 Process for preparing clopidogrel
KR1020067008009A KR20060040758A (ko) 2001-01-24 2002-01-21 티에노[3,2-ｃ]피리딘 유도체의 제조방법
KR1020037009826A KR100632748B1 (ko) 2001-01-24 2002-01-21 티에노[3,2-ｃ]피리딘 유도체의 제조방법
EP02710298A EP1353928B1 (en) 2001-01-24 2002-01-21 Process for preparing clopidogrel
ES02710298T ES2278010T3 (es) 2001-01-24 2002-01-21 Procedimiento de preparacion de clopidrogel.
PCT/IN2002/000012 WO2002059128A2 (en) 2001-01-24 2002-01-21 Process for preparing clopidogrel
MXPA03006133A MXPA03006133A (es) 2001-01-24 2002-01-21 Proceso para preparar clopidogrel.
BR0207064-2A BR0207064A (pt) 2001-01-24 2002-01-21 Processo para a preparação de um composto
AU2002228325A AU2002228325B2 (en) 2001-01-24 2002-01-21 Process for preparing clopidogrel
CNB02803998XA CN100338068C (zh) 2001-01-24 2002-01-21 制备氯吡格雷的方法
DE60217062T DE60217062T2 (de) 2001-01-24 2002-01-21 Verfahren zur herstellung von clopidogrel
DK02710298T DK1353928T3 (da) 2001-01-24 2002-01-21 Fremgangsmåde til fremstilling af clopidogrel
CA2436323A CA2436323C (en) 2001-01-24 2002-01-21 Process for preparing clopidogrel
AT02710298T ATE349451T1 (de) 2001-01-24 2002-01-21 Verfahren zur herstellung von clopidogrel
NO20032898A NO327807B1 (no) 2001-01-24 2003-06-24 Fremgangsmate for fremstilling av klopidogrel
ZA200304895A ZA200304895B (en) 2001-01-24 2003-06-24 Process for preparing clopidogrel.
CY20071100280T CY1106346T1 (el) 2001-01-24 2007-02-28 Μεθοδος για την παρασκευη της ενωσης clopidogrel
JP2008179540A JP2009029805A (ja) 2001-01-24 2008-07-09 クロピドグレルの製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN84MU2001 IN191030B (ar) 2001-01-24 2001-01-24

Publications (1)

Publication Number Publication Date
IN191030B true IN191030B (ar) 2003-09-13

Family

ID=11097211

Family Applications (1)

Application Number Title Priority Date Filing Date
IN84MU2001 IN191030B (ar) 2001-01-24 2001-01-24

Country Status (6)

Country Link
US (1) US6635763B2 (ar)
JP (1) JP2009029805A (ar)
KR (1) KR100632748B1 (ar)
IN (1) IN191030B (ar)
PT (1) PT1353928E (ar)
ZA (1) ZA200304895B (ar)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2363053C (en) * 2001-11-09 2011-01-25 Bernard Charles Sherman Clopidogrel bisulfate tablet formulation
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6800759B2 (en) 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
US7872019B2 (en) * 2003-03-12 2011-01-18 Cadila Healthcare Limited Polymorphs and amorphous form of (S)-(+)-clopidogrel bisulfate
DE04770646T1 (de) 2003-04-25 2011-12-08 Cadila Healthcare Ltd. Salze von clopidogrel und herstellungsverfahren
US20050059696A1 (en) * 2003-05-08 2005-03-17 Dr. Reddy's Laboratories Limited Process for the recovery of S -(+)-methyl- (2-chlorophenyl)- (6,7-dihydro- 4H-thieno [3,2-c] pyrid-5-yl) acetate hydrogen sulfate (clopidogrel bisulfate) from its (R) and mixture of (R) and (S)- isomers
WO2005063708A2 (en) * 2003-11-03 2005-07-14 Cadila Healthcare Limited Processes for preparing different forms of (s)-(+)- clopidogrel bisulfate
CA2457459A1 (en) * 2004-02-11 2005-08-11 Brantford Chemicals Inc. Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
EP1723141A4 (en) * 2004-03-05 2007-10-10 Ipca Lab Ltd MOST TECHNICAL PROCESS FOR THE PREPARATION OF CLOPIDOGRAPHYDROGENSULFATE
KR100563455B1 (ko) * 2004-04-09 2006-03-23 한미약품 주식회사 결정성 클로피도그렐 나프탈렌술폰산염 또는 이의 수화물,이의 제조방법 및 이를 함유하는 약학적 조성물
KR100681512B1 (ko) * 2005-03-08 2007-02-09 주식회사 한서켐 클로피도그렐의 신규한 제조 중간체 및 이를 이용한 클로피도그렐의 제조방법
BRPI0608771A2 (pt) * 2005-05-10 2010-01-26 Elan Pharma Int Ltd formulações de clopidogrel em nanopartìcula
CN101237868A (zh) * 2005-06-13 2008-08-06 伊兰制药国际有限公司 纳米粒氯吡格雷和阿司匹林组合制剂
KR100678287B1 (ko) * 2005-06-23 2007-02-02 한미약품 주식회사 클로피도그렐의 제조방법 및 이에 사용되는 중간체
WO2007052300A2 (en) 2005-09-05 2007-05-10 Cadila Healthcare Limited Processes for the preparation of different forms of (s)-(+)-clopidogrel besylate
KR20070066518A (ko) * 2005-12-22 2007-06-27 에스케이케미칼주식회사 고체상 반응을 이용한 (ｓ)-(＋)-클로피도그렐의 제조방법
KR101235117B1 (ko) * 2005-12-26 2013-02-20 에스케이케미칼주식회사 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법
US20070191609A1 (en) * 2006-02-13 2007-08-16 Lee Pharma Limited Process for preparation of clopidogrel bisulphate form-1
KR20080055860A (ko) * 2006-08-03 2008-06-19 테바 파마슈티컬 인더스트리즈 리미티드 클로피도그렐 바이설페이트의 제조 방법
US8247558B2 (en) * 2006-09-04 2012-08-21 Ranbaxy Laboratories Limited Process for the preparation of clopidogrel and its pharmaceutically acceptable salts
WO2008081473A2 (en) * 2006-12-29 2008-07-10 Cadila Healthcare Limited Process for preparing clopidogrel
BRPI0803101A2 (pt) * 2007-04-18 2014-04-22 Teva Pharma Processos melhores para preparação de clopidogrel
US20110190502A1 (en) * 2008-10-24 2011-08-04 Sandoz Ag Process for the preparation of s-clopidogrel
CN101695496A (zh) * 2009-10-15 2010-04-21 苏春华 一种含有三氟柳和氯吡格雷的药物组合物
WO2012123958A1 (en) 2011-02-14 2012-09-20 Cadila Healthcare Limited Highly pure salts of clopidogrel free of genotoxic impurities
WO2023012479A1 (en) 2021-08-03 2023-02-09 Liqmeds Worldwide Limited An oral pharmaceutical solution of clopidogrel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
HU222283B1 (hu) * 1997-05-13 2003-05-28 Sanofi-Synthelabo Eljárás tieno[3,2-c]piridin-származékok előállítására
ATE349451T1 (de) * 2001-01-24 2007-01-15 Cadila Healthcare Ltd Verfahren zur herstellung von clopidogrel

Also Published As

Publication number Publication date
KR100632748B1 (ko) 2006-10-11
JP2009029805A (ja) 2009-02-12
ZA200304895B (en) 2004-05-12
US6635763B2 (en) 2003-10-21
KR20030081398A (ko) 2003-10-17
PT1353928E (pt) 2007-03-30
US20020177712A1 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
BE2022C531I2 (ar)
BE2022C547I2 (ar)
BE2017C056I2 (ar)
BE2017C051I2 (ar)
BE2017C032I2 (ar)
BE2016C051I2 (ar)
BE2015C077I2 (ar)
BE2015C046I2 (ar)
BE2014C052I2 (ar)
BE2014C036I2 (ar)
BE2014C026I2 (ar)
BE2017C050I2 (ar)
JP2002216017A5 (ar)
JP2002010364A5 (ar)
JP2002098430A5 (ar)
JP2002195874A5 (ar)
BRPI0209186B1 (ar)
BE2016C021I2 (ar)
JP2002038903A5 (ar)
BRPI0204884B1 (ar)
CH1379220H1 (ar)
BE2017C059I2 (ar)
IN191030B (ar)
JP2001319481A5 (ar)
JP2002213617A5 (ar)